Application 022363

Type
NDA
Sponsor
KOWA CO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LIVALOPITAVASTATIN CALCIUMTABLET;ORALEQ 1MG BASEYesNo
002LIVALOPITAVASTATIN CALCIUMTABLET;ORALEQ 2MG BASEYesNo
003LIVALOPITAVASTATIN CALCIUMTABLET;ORALEQ 4MG BASEYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
66869-104Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-104Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-104Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-204Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-204Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-204Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-404Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-404Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent
66869-404Livalopitavastatin calciumKowa Pharmaceuticals America, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77844SUPPL 2024-03-15
77837SUPPL 2024-03-15
72596SUPPL2022-11-10
72595SUPPL2022-11-10
64731SUPPL2020-09-29
64704SUPPL2020-09-28
60614SUPPL2019-10-22
60610SUPPL2019-10-21
58820SUPPL2019-05-21
58772SUPPL2019-05-17
45918SUPPL2016-11-22
45936SUPPL2016-11-21
38627SUPPL2013-10-18
29657SUPPL2013-10-18
38626SUPPL2012-11-06
29656SUPPL2012-11-06
22004SUPPL2012-04-24
22003SUPPL2012-03-30
38625SUPPL2012-02-28
29655SUPPL2012-02-28
17297SUPPL2012-02-28
7297SUPPL2012-02-28
29654SUPPL2011-08-05
17296SUPPL2011-08-05
29653SUPPL2011-06-27
17295SUPPL2011-06-16
7296SUPPL2010-06-08
42500ORIG2009-11-23
38624ORIG2009-08-26
7295ORIG2009-08-26
64049ORIG1900-01-01
64048ORIG1900-01-01
63238SUPPL1900-01-01
63237SUPPL1900-01-01
63236SUPPL1900-01-01
63235SUPPL1900-01-01